Diamyd Medical AB (publ)
SSE:DMYD-B.ST
13.3 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||||||
Net Income
| -151.85 | -120.806 | -118.176 | -85.88 | 9.739 | -36.569 | -44.036 | -25.52 | -32.059 | -21.568 | -16.732 | -13.032 | -51.675 | 111.339 | -2.962 |
Depreciation & Amortization
| 5.58 | 4.869 | 4.383 | 0.782 | 0.149 | 0.14 | 0.131 | 0.106 | 0.106 | 0.026 | 0.108 | 0.155 | 17.141 | 0.428 | 0.224 |
Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change In Working Capital
| -13.502 | -1.447 | 17.521 | -24.661 | 6.987 | -1.801 | 3.24 | 0.292 | 0.644 | 0.98 | -0.676 | 0.671 | -22.165 | 7.572 | 227.63 |
Accounts Receivables
| -13.502 | 0.066 | 10.095 | -19.566 | 1.134 | -2.085 | 2.269 | -3.793 | -0.623 | 0.636 | 0.061 | 0.023 | 0 | 0 | 0 |
Inventory
| 0 | 1.513 | -7.426 | 5.095 | -5.853 | -0.284 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.009 |
Accounts Payables
| 21.411 | -1.513 | 7.426 | -5.095 | 5.853 | 0.284 | 0.971 | 4.086 | 1.267 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Working Capital
| 0 | -1.513 | 7.426 | -5.095 | 5.853 | 0.284 | 0.971 | 4.085 | 1.267 | 0.344 | -0.737 | 0.648 | 0 | 7.562 | 227.621 |
Other Non Cash Items
| 30.591 | 6.422 | 3.053 | 0.291 | 0.005 | -0.955 | -0.899 | -0.686 | 13.557 | 2.251 | 0.61 | -1.509 | 0.712 | -213.366 | 0.882 |
Operating Cash Flow
| -129.181 | -110.962 | -93.219 | -109.468 | 16.88 | -39.185 | -41.564 | -25.808 | -17.752 | -18.311 | -16.69 | -13.715 | -55.987 | -94.027 | 225.774 |
Investing Activities: | |||||||||||||||
Investments In Property Plant And Equipment
| -8.025 | -11.442 | -34.652 | -4.225 | -1.979 | 0 | -0.347 | 0 | 0 | -0.4 | -0.13 | 0 | -0.093 | -1.928 | -0.7 |
Acquisitions Net
| 0 | -39.843 | 6.653 | 144.413 | -6.8 | 0 | 0 | 0 | 0 | 0 | 0 | 36.882 | 0 | 0 | 0 |
Purchases Of Investments
| -40.351 | -0.064 | -129.891 | -20.477 | -33.201 | -94.721 | -0.004 | -27.884 | -2.334 | -4.045 | -24.015 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 20.383 | 39.907 | 96.637 | 157.236 | 40.001 | 100.07 | 0 | 0 | 7.999 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| -19.969 | 39.843 | -15.469 | -144.414 | 6.8 | 0.001 | -0.001 | -0.001 | 5.665 | 0.001 | -24.015 | 36.882 | 61.989 | -277.859 | 0 |
Investing Cash Flow
| -27.994 | 28.401 | -76.722 | 132.533 | 4.821 | 5.35 | -0.352 | -27.885 | 5.665 | -4.444 | -24.145 | 36.882 | 61.896 | -279.787 | -0.7 |
Financing Activities: | |||||||||||||||
Debt Repayment
| -14.807 | -15.865 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock Issued
| 127.477 | 75.271 | 150 | 60 | 0 | 58.403 | 0 | 88.816 | 22.119 | 15 | 0 | 20.705 | 0.288 | 37.559 | 238.861 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 142.284 | 27.136 | -7.845 | -3.276 | 0 | -2.023 | 0.298 | -5.858 | -0.372 | -0.044 | -0.095 | -0.319 | 0 | 0 | 0 |
Financing Cash Flow
| 142.284 | 86.542 | 142.155 | 56.724 | -0.001 | 56.38 | 0.298 | 82.958 | 21.747 | 14.956 | -0.095 | 20.386 | 0.288 | 37.559 | 238.861 |
Other Information: | |||||||||||||||
Effect Of Forex Changes On Cash
| 0.116 | 3.791 | 8.171 | 1.221 | -0.035 | 0.081 | -0.001 | 0.032 | 0.008 | -0.186 | 0.127 | 0.005 | 0.363 | -7.295 | 0.11 |
Net Change In Cash
| -14.775 | 7.772 | -19.615 | 81.009 | 21.665 | 22.625 | -41.618 | 29.298 | 9.668 | -7.986 | -40.803 | 43.558 | 6.56 | -343.55 | 464.045 |
Cash At End Of Period
| 112.758 | 127.533 | 119.761 | 139.376 | 58.367 | 36.702 | 14.077 | 55.695 | 26.397 | 16.729 | 24.715 | 65.518 | 164.342 | 157.782 | 501.332 |